The Prescription Drug Monitoring Program Training and Technical Assistance Center (PDMP TTAC) reports 2020 data and 2021 features of the Nebraska state Prescription Drug Monitoring Program (PDMP).
The acronym for the Nebraska PDMP is NEHII. It is administered by the Department of Health. The email address is provided, along with the URLs for the PDMP website and a website with relevant statutes and regulations. Contact information is provided for VP Pharmacy Informatics and Lead Pharmacy Informatics. In 2020, the state population was 1,963,333, and there were 12,371 DEA-registered prescribers and 454 DEA-recognized dispensers. Nine data transmitters are listed. Substances monitored are those listed on Schedules II-V and naloxone/narcan dispensations. An alternate data source is patient lock-in information. There are 10 types of reports available from the PDMP. Four statistical capabilities are listed. Thirteen types of authorized PDMP users are listed, including prescribers, dispensers, Medicaid staff, healthcare professionals, and patients. Fourteen types of engaged PDMP users are listed. No information is provided on the budget or funding sources. One PDMP staff member is responsible for operations; two work on the technical aspects of PDMP and two part-time employees are responsible for analytical and “other” responsibilities. Funding sources are a CDC grant and CMS grants. No information is provided on the 2021 annual budget. Technologies involved in the PDMP are listed. Training on enrollment and use is provided for dispensers and prescribers. Criteria for PDMP queries are noted, along with the frequency and delivery methods for unsolicited reports/push notifications. PDMP requirements for enrollment and use of the PDMP by veterinarians are reported.
Similar Publications
- Opioid Affected Youth Initiative (OAYI) Podcast Answering the Call: Addressing Not Arresting
- Effect of a Multimodal Analgesic Protocol on Short-Term and Long-Term Opioid Use After Orthopaedic Trauma
- Cuyahoga County, Ohio, Heroin and Crime Initiative: Informing the Investigation and Prosecution of Heroin-Related Overdose, Research Abstract